5 can't-miss events at Houston Tech Rodeo 2023

where to be

These are the events to attend each day during the Houston Tech Rodeo 2023. Photo via Getty Images

Houston innovators — a week of panels, networking opportunities, and more has been coordinated just for you. Are you ready to make the most of it?

Houston Tech Rodeo from Houston Exponential officially starts next week with swag pick up on Sunday, February 26. The programming runs from Monday, February 27, through Thursday, March 2, and wraps up with a chili cook off on Saturday, March 4. There are 30 events to choose from across the Houston innovation corridor near downtown. The full schedule, which launched earlier this month, is available online. Check it out to register for what all you want to attend and for more detailed info.

Each day has themes — space, life science, energy, emerging tech, etc. — and one to two locations for activations. Every day has a happy hour for those interested in networking opportunities, panels for opportunities to hear from industry experts, and more.

Here are five of the Houston Tech Rodeo events you definitely want to make sure you attend.

Networking — #LaunchCity Happy Hour

Start off the week strong with a happy hour at The Ion from 6 to 8 pm on Monday, February 27. The networking event wraps up the first full day of Tech Rodeo and follows space tech-focused programming. If you're able to make it earlier, don't miss the Founder's Live pitch event at Common Desk starting at 3:30 pm or the Future of Space Tech panel at 4:15 pm that will feature representatives from NASA, Axiom, and Intuitive Machines.

Panel — Navigating the Entrepreneurial Landscape: Accessing the Resources You Need to Succeed

If you're a Houston founder, you won't want to miss the first panel of day two of Tech Rodeo. The panel, "Navigating the Entrepreneurial Landscape: Accessing the Resources You Need to Succeed," starts at 9 am on Tuesday, February 28, and will feature experts from a handful of organizations who will speak to resources available for startups and small businesses. The full morning of programing will be hosted at Houston Community College's Central Campus.

Pitch — Rodeo for the Rest of Us Reverse Pitch

Sesh Coworking is hosting an inclusive networking breakfast on Thursday, March 2, beginning at 9 am and followed by a unique opportunity for startups. Sesh is flipping the script on the traditional pitch process and putting the mics in the hands of investors. Expect direct access to these VCs and angels at the Rodeo For the Rest of Us reverse pitch as well as more networking over lunch.

Meeting — Houston Innovation Town Hall

Don't miss the unique opportunity to hear from the Houston innovation community at this unique event. The town hall on Thursday, March 2, will start with announcements from HX and a few other players in the ecosystem, and wrap up with a conversation with Houston's mayoral candidates — Chris Hollins, Lee Kaplan, and Amanda K Edwards — that begins at 4 pm at 713 Music Hall in the Post.

Competition — CodeLaunch by Improving

The weeks programming concludes with a high energy event and startup pitch competition. CodeLaunch by Improving, which announced its finalists earlier this month, will host its main event at 713 Music Hall from 6 to 9 pm. RSVP to Tech Rodeo to get your ticket to the event.


Houston Tech Rodeo returns with in-person events — here are the must-attend panels, networking opportunities, and more. Photo by Nijalon Dunn

5 can't-miss events at Houston Tech Rodeo 2022

where to be

Saddle up, Space City. Houston Exponential's Houston Tech Rodeo is back for its third year — and the innovation-focused programing returns with in-person events scattered in downtown and beyond.

The week-long event is organized by themes and hubs. For example, WeWork Downtown will host conversations on consumer packaged goods and food tech on Monday, while health tech programing will take place Thursday at Texas A&M's EnMed building. The full schedule is available online and registration is completely free, but if you'd like to attend some can't miss panels and events, look no further than this guide below.

Feb. 28 — Lasso The Moon

What do civil, commercial, and military players need from Houston’s innovation and academic communities to solve our most far-reaching challenges? Join the Space Force Association and TexSpace for a multi-disciplinary presentation and roundtable discussion with networking and tabletop exhibits that aim high. The event features SpaceForce, Limitless Space Institute, Axiom Space, Intuitive Machines, and more.

The event takes place on Monday, Feb. 28, from 1 to 5 pm at The Ion Houston (4201 Main St.)

March 1 — Investing in ClimateTech

This discussion will bring together local VCs to discuss sourcing, diligencing, and investing in climatetech solutions, as well as how Houston is perfectly positioned to benefit from this momentum.

Speakers:

  • Ernst Sack, Blue Bear Capital
  • Eric Rubenstein, Managing Partner, New Climate Ventures
  • Amy Henry, CEO/Co-Founder, Eunike Ventures
  • Moderated by Juliana Garaizar, VIP of Innovation and Head of Houston Incubator, Greentown Labs

The event takes place on Tuesday, March 1, from 1:30 to 2:30 pm at Greentown Houston (4200 San Jacinto St.)

March 2 — The Founder Institute Texas Showcase

It's Tech Rodeo time which means we've rounded up several strong local founders to pitch as well as recognized experts to judge and AMA panel. This year we'll be available in-person at Houston's Downtown Launchpad as well as live-streaming & replaying the pitches and an impactful AMA. Join for best-in-class startup networking afterwards.

The event takes place on Wednesday, March 2, from 12:30 to 3 pm at Downtown Launchpad (10th floor, 1801 Main St.)

March 3 — Four Fierce Females - Innovator, Igniter, Inventor, Investor

Talk about girl power. Four female panelists engage in a health tech conversation from their four points of view as an innovator, igniter, inventor, and investor. Houston Methodist is hosting the entire morning's conversations from 8:30 am to noon.

  • Michelle Stansbury – Houston Methodist
  • Ayse McCracken – Ignite Healthcare Network
  • Emma Fauss - Medical Informatics
  • Samantha Lewis - Mercury Fund

The event takes place on Thursday, March 3, from 9:30 to 10:15 am at Texas A&M EnMed building (1020 Holcombe Blvd.)

March 4 — Tech Rodeo Career Fair

HTX Talent and the University of Houston Downtown Career Centers (Main Career Center and the Marilyn Davies Career Center) has introduced the first Tech Rodeo Career Fair. Top tech companies will connect with talented job seekers from all over the Houston community and surrounding areas. Learn what type of positions employers are looking for, meet recruiters and companies that fit your job profile, and grow your network.

Register to attend here: https://bit.ly/3GtcKaR

Employer registration here: https://bit.ly/3Amo7zB

The event takes place on Friday, March 4, from 1 to 4 pm at The University of Houston - Downtown.

Bonus: Where to network at HTR

A huge portion of HTR is getting the community out and about to meet, network, and share ideas and energy. There are plenty of opportunities to do so, including the following events:

  • Swag pickup (Sunday, Feb. 27, from 1 to 4 pm.) at McIntyre's Downtown (901 Commerce St.)
  • Cup of Joey (Daily, from 7 to 8:45 am) at Finn Hall (712 Main St.). Note: Coffee networking takes place at Texas A&M's EnMed building on Thursday, March 3.
  • Happy Hour and Mini-Showcase at Greentown Labs (Tuesday, March 1, from 5 to 7 pm) at Greentown Labs (4200 San Jacinto St.)
  • Techqueria at the Tech Rodeo (Wednesday, March 4, from 3:30 to 8:30 pm) at West Houston Cannon Location (1334 Brittmoore Rd.)
  • What's Your Anthem? A Happy Hour hosted by Accenture & Hines (Wednesday, March 4, from 5 to 7 pm) at The Square by Hines (717 Texas St, Floor 12)
  • Inclusive Innovation Community Happy Hour (Thursday, March 3, from 5 to 7 pm) at Weights + Measures (2808 Caroline St.)
  • Tech Rodeo Block Party (Friday, March 4, from 7 to 9 pm) at Main Street 300 block (between Congress and Preston)

All of these events have more details on the HTR website, which can be accessed here once you are registered.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings